0001562180-22-005608.txt : 20220706
0001562180-22-005608.hdr.sgml : 20220706
20220706200709
ACCESSION NUMBER: 0001562180-22-005608
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220701
FILED AS OF DATE: 20220706
DATE AS OF CHANGE: 20220706
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Russell Kerry Strong
CENTRAL INDEX KEY: 0001927137
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39926
FILM NUMBER: 221070391
MAIL ADDRESS:
STREET 1: C/O TERNS PHARMACEUTICALS, INC.
STREET 2: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001831363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-525-5535 EXT.101
MAIL ADDRESS:
STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-07-01
false
0001831363
Terns Pharmaceuticals, Inc.
TERN
0001927137
Russell Kerry Strong
C/O TERNS PHARMACEUTICALS, INC.
1065 E. HILLSDALE BLVD., SUITE 100
FOSTER CITY
CA
94404
false
true
false
false
Chief Medical Officer
Stock Option (Right to Buy)
2.69
2022-07-01
4
A
false
240000.00
0.00
A
2032-06-30
Common Stock
240000.00
240000.00
D
25% of the shares subject to the option vest on the first anniversary measured from May 31, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
/s/ Bryan Yoon, as Attorney-in-Fact for Kerry Strong Russell
2022-07-06